Stand Up for Science! Video Contest
From the creation of flu vaccines and new cancer therapies to enhancing agriculture and developing biofuels, bioscience breakthroughs are transforming our world and our health at a rapid pace. However, many Americans are not aware of the critical role the US federal government plays in supporting biological research and discovery. We are looking for you to create an exciting, yet informative video to help educate Americans on how science is funded! The contest is open to individual entrants residing in the U.S. who are at least 13 years of age at the time of entry. The video should be between 1-4 mi...
Source: ScanGrants feed - November 6, 2013 Category: Research Authors: Federation of American Societies for Experimental Biology Source Type: funding
Clarification of the Scope of Research Projects to be Supported by PAR-11-150 Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)
Notice NOT-CA-13-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2013 Category: Research Source Type: funding
Call for Cancer Projects: Repurposing of Drugs - Breakthrough in Cancer Treatment
Funding Cancer Projects Reliable Cancer Therapies (RCT) announces € 300 000 for projects repurposing existing drugs for cancer treatment. The drugs must have been developed and approved for other indication(s). Relevant clinical trial endpoints (cancer survival & tumor response) should be the primary research assessments. RCT also promotes collaborative research projects between researchers at different universities and/or organisations. About the Call for Applications • Medical Degree required for Principal Investigator (PI) or co-PI • 1 application per PI • Resub...
Source: ScanGrants feed - May 6, 2013 Category: Research Authors: Reliable Cancer Therapies Source Type: funding
Travel Fellowships for Nanotechnologies in Cancer Diagnosis, Therapy, and Prevention
June 11 - 13, 2013 Moscow, Russia World Trade Center Moscow Congress Center Presented by The New York Academy of Sciences, the Mushett Family Foundation, and the Skolkovo Institute of Science and Technology Poster Abstract Deadline: April 24, 2013 Harnessing principles from chemistry, biology, physics, and engineering, nanotechnology is a multidisciplinary field still in its infancy. Throughout the past decade, nanoparticles and specifically nanoparticle drug delivery systems, have emerged at the forefront of cancer therapies. Nanotechnology has helped to design and fabricate micro-scale devices, i...
Source: ScanGrants feed - February 11, 2013 Category: Research Authors: New York Academy of Sciences Source Type: funding
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis (ET-CTN) (UM1)
Funding Opportunity Number: RFA-CA-13-006 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCFDA Number: 93.395Eligible Applicants State governmentsPublic and State controlled institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesOthers (see text ...
Source: Grants.gov - February 9, 2013 Category: Research Tags: Education Health Source Type: funding
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis (ET-CTN) (UM1)
Funding Opportunity RFA-CA-13-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI) is to support an experimental therapeutics clinical trials program through the creation of a consolidated, integrated NCI Experimental Therapeutics-Clinical Trials Network (ET-CTN). This FOA solicits UM1 cooperative agreement applications for multidisciplinary groups that will conduct early phase experimental therapeutics clinical trials. Members of the ET-CTN will work on investigational agent-specific trans-network project teams to de...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 8, 2013 Category: Research Source Type: funding
